Correction to: Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China

Adv Ther. 2022 Sep;39(9):4394-4396. doi: 10.1007/s12325-022-02236-9.
No abstract available

Publication types

  • Published Erratum